Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24 weeks: Multicenter, randomized, double-blind, parallel-group, placebo controlled study

Category Primary study
ConferenceDiabetes
Year 2013
This article has no abstract
Epistemonikos ID: 651b0cc4e8cf1cbd4fabb6e180a51328ed3560b0
First added on: Apr 30, 2026